This effect on cell metabolism arising from intercellular crosstalk between CCA and LECs also showed significant changes in the mRNA expression level of crucial metabolic genes such as PFKP, GLUT3, FASN, HK2 and CO I in LECs treated with CCA-CM. The gene discussed is SLC2A3; the disease is cholangiocarcinoma.